The platform allows banks to understand the rationale behind AI-driven lending decisions, offering immediate justifications and highlighting potential biases. This capability not only aids banks in adjusting their algorithms to avoid discrimination but also enables customers to understand and potentially alter their status for future approvals.

Investor Ry Walker, impressed by REZON's innovative approach to addressing neural network biases, supports the venture. REZON also finds applications in healthcare, where it aids in genetic testing by providing instant, verifiable explanations, thereby facilitating quicker, potentially life-saving decisions. REZON stands out for opening the "black box" of AI, making it a critical tool in the quest for accountability and transparency in AI applications.